AusBiotech on Tuesday said it is proposing greater incentives for investors pledging support for start-up and pre-revenue companies. The trade group said it has submitted a supplementary proposal for the government’s tax review and white paper process.
The non-profit industry body for the biotechnology sector, said the lack of long-term venture capital investment in the sector is impacting the industry’s ability to grow at its potential rate.
As per the proposals:
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze